SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-113144
Filing Date
2021-04-12
Accepted
2021-04-12 16:02:29
Documents
10
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 PRE 14A d57994dpre14a.htm PRE 14A 331691
2 GRAPHIC g57994dsp2b.jpg GRAPHIC 1024
3 GRAPHIC g57994dsp3a.jpg GRAPHIC 2275
4 GRAPHIC g57994dsp3b.jpg GRAPHIC 1098
5 GRAPHIC g57994dsp3c.jpg GRAPHIC 949
6 GRAPHIC g57994dsp3d.jpg GRAPHIC 1232
7 GRAPHIC g57994dsp3e.jpg GRAPHIC 1391
8 GRAPHIC g57994dsp4a.jpg GRAPHIC 978
9 GRAPHIC g57994g23u32.jpg GRAPHIC 65162
10 GRAPHIC g57994g65d12.jpg GRAPHIC 46326
  Complete submission text file 0001193125-21-113144.txt   499944
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38268 | Film No.: 21820740
SIC: 2836 Biological Products, (No Diagnostic Substances)